DRAFT AGENDA
Final conference “Our battle for better healthcare is eternal “
70 Years Bulgarian National Cancer Registry
08:30-09:00 – Registration for the day
09:00 -09:05 Introduction and house rules
09:05- 10:30 Session I Pathology & basic science
09:05- 09:25 – Prognostic factors in uterine cancers – Irina Tripac (Moldova)
09:25- 09:45 – Genes, environment and cancer – Antonio Giordano (USA – online)
09:45-10:05 – Immune checkpoint inhibitors in endometrial cancer: Can we add something more? – Velizar Shivarov (Bulgaria)
10:05-10:30 – Discussion
10:30-11:00 Coffee break
11:00-12:30 Session II Biobanking and legal aspects
11:00- 11:20 – Harmonizing a common dataset for biobanking of rare gynaecological cancers – Sharon O’Tole (Ireland)
11:20- 11:40 – Epigenetic regulation of BRCA1 and BRCA2 mRNA expression by promoter methylation and microRNAs in ovarian cancer – Petar Ozretić (Croatia)
11:40- 12:00 – Overview on ovarian cancer stem cells and their role in metastasis and resistance to therapies – Maja Sabol (Croatia)
12:00-12:20 – PARP inhibitors for the treatment of ovarian cancer – Jeannine Marie Dalli & Kyra Fenech (Malta)
12:20-12:30 – Discussion
12:40-13:30 – Lunch
13:30 15:00 Session III Clinical trials and Pharma industry
13:30-13:50 – Definition of good biomarker – Francesca Pentimalli (online)
13:50- 14:10 – Update on the outcomes of completed phase III clinical trials investigating targeted therapies for RGC – Klejda Harasani (Albania)
14:10- 14:30 -Тhe role of pharma in rare diseases – Stephanie Darmanin (Sweden)
14:30-15:00 – Discussion
15:00-15:30 Coffee break
15:30 -17:00 – MC meeting and future plans